The recognition and assessment of cardiovascular risk in people with rheumatoid arthritis in primary care: A questionnaire-based study of general practitioners

Musculoskeletal Care

Volumn 9, Issue 2, 2011, Pages 69-74

  Bell, Carolyn ^a   Rowe, Ian F ^a  

^a WORCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

Author keywords

Cardiovascular disease; Primary care; Rheumatoid arthritis; Risk assessment

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; COMORBIDITY; GENERAL PRACTICE; GENERAL PRACTITIONER; HEALTH SURVEY; HUMAN; PREVALENCE; PRIMARY HEALTH CARE; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR;

ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; COMORBIDITY; GENERAL PRACTICE; GENERAL PRACTITIONERS; HEALTH STATUS INDICATORS; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PREVALENCE; PRIMARY HEALTH CARE; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS;

EID: 79957575110     PISSN: 14782189     EISSN: 15570681     Source Type: Journal    
DOI: 10.1002/msc.196     Document Type: Article

References (17)

1. Chung CP, Oeser A, Avalos I, Gebretsadik T, Shintani A, Raggi P, Sokka T, Pincus T, Stein CM (2006). Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis. Arthritis Research and Therapy 8: R186.
2. Cooper A, Skinner J, Nherera L, Feder G, Ritchie G, Kathoria M, Turnbull N, Shaw G, MacDermott K, Minhas R, Packham C, Squires H, Thomson D, Timmis A, Walsh J, Williams H, White A (2007). Clinical Guidelines and Evidence Review for Post-Myocardial Infarction: Secondary prevention in primary and secondary care for patients following a myocardial infarction. London: National Collaborating Centre for Primary Care and Royal College of General Practitioners.
3. Hall FC, Dalbeth N (2005). Disease modification and cardiovascular risk reduction: two sides of the same coin? Rheumatology 44: 1473-82.
4. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, Brindle P (2008). Predicting cardiovascular risk in England and Wales: Prospective derivation and validation of QRISK2. British Medical Journal 336: 1475-82.
5. Kvien TK (2004). Epidemiology and burden of illness of rheumatoid arthritis. PharmacoEconomics 22(Suppl. 1): 1-12.
6. Luqmani R, Hennell S, Estrach C, Birrell F, Bosworth A, Davenport G, Fokke C, Goodson N, Jeffreson P, Lamb E, Mohammed R, Oliver S, Stableford Z, Walsh D, Washbrook C, Webb F ; British Society for Rheumatology; British Health Professionals in Rheumatology Standards, Guidelines and Audit Working Group (2006). British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (the first two years). Rheumatology 45: 1167-9.
7. Luqmani R, Hennell S, Estrach C, Basher D, Birrell F, Bosworth A, Burke F, Callaghan C, Candal-Couto J, Fokke C, Goodson N, Homer D, Jackman J, Jeffreson P, Oliver S, Reed M, Sanz L, Stableford Z, Taylor P, Todd N, Warburton L, Washbrook C, Wilkinson M; British Society for Rheumatology; British Health Professionals in Rheumatology Standards, Guidelines and Audit Working Group (2009). British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first two years). Rheumatology 48: 436-9.
8. NHS Information Centre. Prescribing Support Unit Quality and Outcomes Framework. Achievement data 2008/09. Available at [Accessed 27 August 2010].
9. Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP, Franklin BA, Goldstein LB, Greenland P, Grundy SM, Hong Y, Miller NH, Lauer RM, Ockene IS, Sacco RL, Sallis JF Jr, Smith SC Jr, Stone NJ, Taubert KA (2002). AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation 106: 388-91.
10. Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, McInnes IB, Haentzschel H, Gonzalez-Gay MA, Provan S, Semb A, Sidiropoulos P, Kitas G, Smulders YM, Soubrier M, Szekanecz Z, Sattar N, Nurmohamed MT (2010). EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Annals of the Rheumatic Diseases 69: 325-31.
11. Radovits BJ, Popa-Diaconu DA, Popa C, Eijsbouts A, Laan RF, van Riel PL, Fransen J (2009). Disease activity as a risk factor for myocardial infarction in rheumatoid arthritis. Annals of the Rheumatic Diseases 68: 1271-6.
12. Solomon DH, Goodson NJ, Katz JN, Weinblatt ME, Avorn J, Setoguchi S, Canning C, Schneeweiss S (2006). Patterns of cardiovascular risk in rheumatoid arthritis. Annals of the Rheumatic Diseases 65: 1608-12.
13. Steen KS, Lems WF, Visman IM, Heierman M, Dijkmans BA, Twisk JW, Boers M, Nurmohamed MT (2009). High incidence of cardiovascular events in patients with rheumatoid arthritis Annals of the Rheumatic Diseases 68: 1509-10.
14. Symmons D, Bruce I (2006). Management of cardiovascular risk in RA and SLE. Hands On. ARC leaflet No. 8.
15. Toms TE, Panoulas VF, Douglas KM, Griffiths H, Sattar N, Smith JP, Symmons DP, Nightingale P, Metsios GS, Kitas GD (2010). Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk. Annals of the Rheumatic Diseases 69: 683-8.
16. TRial of Atorvastatin in the primary prevention of Cardiovascular Endpoints in Rheumatoid Arthritis. Available at [Accessed 27 August 2010].
17. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, Spitz PW, Haga M, Kleinheksel SM, Cathey MA (1994). The mortality of rheumatoid arthritis. Arthritis and Rheumatism 37: 481-94.